STOCK TITAN

Myomo to Participate in the 2024 Maxim Healthcare Virtual Summit

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

Myomo, a wearable medical robotics company, announced its participation in the 2024 Maxim Healthcare Virtual Summit. The event, presented by Maxim Group , will take place from October 15th to 17th. Myomo's president and CEO, Paul Gudonis, along with CFO David Henry, will engage in a 'Fireside Chat' on Wednesday, October 16th at 10:30 a.m. Eastern Time.

The interview will be conducted by Anthony Vendetti, Maxim's Executive Managing Director of Research and Senior Healthcare Analyst. The summit will feature presentations and interactive discussions with CEOs and key management from various healthcare-related companies. Interested participants can sign up for M-Vest membership to attend. Myomo's management is also available for one-on-one meetings with investors, which can be scheduled through LHA Investor Relations.

Myomo, un'azienda di robotica medica indossabile, ha annunciato la sua partecipazione al 2024 Maxim Healthcare Virtual Summit. L'evento, presentato da Maxim Group, si svolgerà dal 15 al 17 ottobre. Il presidente e CEO di Myomo, Paul Gudonis, insieme al CFO David Henry, parteciperà a un 'Fireside Chat' mercoledì, 16 ottobre alle 10:30 ora orientale.

L'intervista sarà condotta da Anthony Vendetti, Direttore Esecutivo della Ricerca e Analista Senior nel Settore Salute di Maxim. Il summit presenterà interventi e discussioni interattive con CEO e dirigenti di aziende operanti nel settore sanitario. I partecipanti interessati possono registrarsi per diventare membri di M-Vest per partecipare. La direzione di Myomo è inoltre disponibile per incontri individuali con gli investitori, che possono essere programmati tramite LHA Investor Relations.

Myomo, una empresa de robótica médica portátil, anunció su participación en la Cumbre Virtual de Atención Médica de Maxim 2024. El evento, presentado por Maxim Group, se llevará a cabo del 15 al 17 de octubre. El presidente y CEO de Myomo, Paul Gudonis, junto con el CFO David Henry, participará en una 'Charla Junto a la Chimenea' el miércoles 16 de octubre a las 10:30 a.m. hora del Este.

La entrevista será conducida por Anthony Vendetti, Director Ejecutivo de Investigación y Analista Senior en Salud de Maxim. La cumbre contará con presentaciones y discusiones interactivas con CEOs y gerentes clave de diversas empresas relacionadas con la atención médica. Los participantes interesados pueden registrarse para ser miembros de M-Vest y asistir. La dirección de Myomo también está disponible para reuniones individuales con inversores, que pueden programarse a través de LHA Investor Relations.

Myomo, 착용 가능한 의료 로봇 회사, 2024 Maxim Healthcare Virtual Summit에 참가한다고 발표했습니다. Maxim Group에서 주최하는 이 행사는 10월 15일부터 17일까지 개최됩니다. Myomo의 회장 겸 CEO인 Paul Gudonis와 CFO인 David Henry가 10월 16일 수요일 오전 10시 30분 동부 표준시에 '파이어사이드 채팅'에 참여할 예정입니다.

인터뷰는 Maxim의 연구 부문 전무 이사이자 선임 의료 분석가인 Anthony Vendetti가 진행합니다. 이번 서밋은 다양한 의료 관련 회사의 CEO들과 주요 경영진과의 발표 및 인터랙티브 토론을 특징으로 합니다. 참석을 원하는 참가자는 M-Vest 회원가입을 통해 참석할 수 있습니다. Myomo 경영진은 투자자와의 일대일 회의도 가능하며, 이는 LHA Investor Relations를 통해 예약할 수 있습니다.

Myomo, une entreprise de robotique médicale portable, a annoncé sa participation au Sommet Virtuel de Santé Maxim 2024. L'événement, présenté par Maxim Group, se déroulera du 15 au 17 octobre. Le président et PDG de Myomo, Paul Gudonis, ainsi que le CFO David Henry, participeront à une 'Discussion au Coin du Feu' le mercredi 16 octobre à 10h30, heure de l'Est.

L'interview sera menée par Anthony Vendetti, Directeur Général Exécutif de la Recherche et Analyste Principal en Santé chez Maxim. Le sommet proposera des présentations et des discussions interactives avec des PDG et des dirigeants clés de diverses entreprises liées à la santé. Les participants intéressés peuvent s'inscrire pour devenir membre de M-Vest afin d'assister. La direction de Myomo est également disponible pour des réunions individuelles avec des investisseurs, qui peuvent être planifiées via LHA Investor Relations.

Myomo, ein Unternehmen für tragbare medizinische Robotik, hat seine Teilnahme am 2024 Maxim Healthcare Virtual Summit angekündigt. Die Veranstaltung, die von Maxim Group präsentiert wird, findet vom 15. bis 17. Oktober statt. Myomos Präsident und CEO, Paul Gudonis, sowie CFO David Henry werden am Mittwoch, den 16. Oktober um 10:30 Uhr Eastern Time an einem 'Fireside Chat' teilnehmen.

Das Interview wird von Anthony Vendetti, dem Executive Managing Director of Research und Senior Healthcare Analyst von Maxim, durchgeführt. Der Gipfel wird Präsentationen und interaktive Diskussionen mit CEOs und Schlüsselmanagern aus verschiedenen gesundheitsbezogenen Unternehmen bieten. Interessierte Teilnehmer können sich für eine M-Vest-Mitgliedschaft anmelden, um teilzunehmen. Das Management von Myomo steht auch für persönliche Gespräche mit Investoren zur Verfügung, die über LHA Investor Relations geplant werden können.

Positive
  • None.
Negative
  • None.

BOSTON--(BUSINESS WIRE)-- Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that Paul Gudonis, president and chief executive officer, and David Henry, chief financial officer, will participate in a “Fireside Chat” at the 2024 Maxim Healthcare Virtual Summit. The virtual summit is being presented by Maxim Group LLC, from October 15th to 17th. Mr. Gudonis and Mr. Henry will be interviewed by Anthony Vendetti, Maxim’s Executive Managing Director of Research and Senior Healthcare Analyst on Wednesday, October 16th at 10:30 a.m. Eastern Time.

Maxim Senior Analysts will host a wide range of biotechnology, diagnostic, medical device, and healthcare information technology companies in a series of presentations and interactive discussions with CEOs and key management. To attend, just sign up to become an M-Vest member and stay tuned for more updates. Click here to reserve your seat.

Management is available for 1x1 meetings with investors. Please contact Kim Golodetz at LHA Investor Relations to schedule a meeting.

About Myomo

Myomo, Inc. is a wearable medical robotics company that offers improved arm and hand function for those suffering from neurological disorders and upper-limb paralysis. Myomo develops and markets the MyoPro product line. MyoPro is a powered upper-limb orthosis designed to support the arm and restore function to the weakened or paralyzed arms of certain patients suffering from CVA stroke, brachial plexus injury, traumatic brain or spinal cord injury or other neuromuscular disease or injury. It is currently the only marketed device in the U.S. that, sensing a patient’s own EMG signals through non-invasive sensors on the arm, can restore an individual’s ability to perform activities of daily living, including feeding themselves, carrying objects and doing household tasks. Many are able to return to work, live independently and reduce their cost of care. Myomo is headquartered in Boston, Massachusetts, with sales and clinical professionals across the U.S. and representatives internationally. For more information, please visit www.myomo.com.

For Myomo:

ir@myomo.com

Investor Relations:

Kim Sutton Golodetz

LHA Investor Relations

kgolodetz@lhai.com

212-838-3777

Source: Myomo, Inc.

FAQ

When is Myomo (MYO) participating in the 2024 Maxim Healthcare Virtual Summit?

Myomo (MYO) is participating in the 2024 Maxim Healthcare Virtual Summit from October 15th to 17th, with their 'Fireside Chat' scheduled for Wednesday, October 16th at 10:30 a.m. Eastern Time.

Who will represent Myomo (MYO) at the 2024 Maxim Healthcare Virtual Summit?

Paul Gudonis, president and CEO, and David Henry, CFO, will represent Myomo (MYO) at the 2024 Maxim Healthcare Virtual Summit.

How can investors attend Myomo's (MYO) presentation at the Maxim Healthcare Virtual Summit?

Investors can attend by signing up to become an M-Vest member. The link to reserve a seat is provided in the press release.

Are one-on-one meetings available with Myomo (MYO) management during the summit?

Yes, Myomo (MYO) management is available for one-on-one meetings with investors. These can be scheduled through Kim Golodetz at LHA Investor Relations.

Myomo Inc.

NYSE:MYO

MYO Rankings

MYO Latest News

MYO Stock Data

113.35M
30.23M
13.05%
49.67%
3.2%
Medical Devices
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Link
United States of America
BOSTON